ATE161883T1 - Rezeptor für granulozyten-macrophagen- koloniestimulierungsfaktor und seine derivate - Google Patents

Rezeptor für granulozyten-macrophagen- koloniestimulierungsfaktor und seine derivate

Info

Publication number
ATE161883T1
ATE161883T1 AT90912329T AT90912329T ATE161883T1 AT E161883 T1 ATE161883 T1 AT E161883T1 AT 90912329 T AT90912329 T AT 90912329T AT 90912329 T AT90912329 T AT 90912329T AT E161883 T1 ATE161883 T1 AT E161883T1
Authority
AT
Austria
Prior art keywords
csf
receptor
derivatives
stimulating factor
macrophage colony
Prior art date
Application number
AT90912329T
Other languages
English (en)
Inventor
Nicos Anthony Nicola
Nicholas Martin Gough
David Paul Gearing
Donald Metcalf
Julie Ann King
Original Assignee
Amrad Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amrad Corp Ltd filed Critical Amrad Corp Ltd
Application granted granted Critical
Publication of ATE161883T1 publication Critical patent/ATE161883T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT90912329T 1989-08-11 1990-08-10 Rezeptor für granulozyten-macrophagen- koloniestimulierungsfaktor und seine derivate ATE161883T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ574389 1989-08-11
AUPK001490 1990-05-08

Publications (1)

Publication Number Publication Date
ATE161883T1 true ATE161883T1 (de) 1998-01-15

Family

ID=25643733

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90912329T ATE161883T1 (de) 1989-08-11 1990-08-10 Rezeptor für granulozyten-macrophagen- koloniestimulierungsfaktor und seine derivate

Country Status (10)

Country Link
US (2) US5726036A (de)
EP (1) EP0486572B1 (de)
JP (1) JP3267966B2 (de)
AT (1) ATE161883T1 (de)
AU (1) AU637133B2 (de)
CA (1) CA2064814C (de)
DE (1) DE69031914T2 (de)
DK (1) DK0486572T3 (de)
SG (1) SG59954A1 (de)
WO (1) WO1991002063A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747032A (en) * 1990-08-10 1998-05-05 Amrad Corporation Limited Monoclonal antibody to human granulocyte macrophage colony stimulating factor
AU673858B2 (en) * 1992-10-09 1996-11-28 Amrad Operations Pty. Limited Monoclonal antibody
CA2149881A1 (en) * 1992-11-19 1994-05-26 Paul T. Jubinsky Antibodies for gm-csf receptor and uses thereof
ATE360689T1 (de) * 1996-09-10 2007-05-15 Kocher Theodor Inst Cxcr3 chemokine rezeptor, antikoerper, nukleinsaeure und deren verfahren zur anwendung
US6140064A (en) 1996-09-10 2000-10-31 Theodor-Kocher Institute Method of detecting or identifying ligands, inhibitors or promoters of CXC chemokine receptor 3
US20020009724A1 (en) * 1999-12-08 2002-01-24 Robert Schlegel Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
US7247618B2 (en) * 2001-04-30 2007-07-24 Tripathi Rajavashisth Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
WO2005038055A1 (en) * 2003-09-22 2005-04-28 Nathaniel Tue Tran Multiplexing array techniques
SI1999152T1 (sl) * 2006-03-27 2013-02-28 Medimmune Limited Vezni äślen za gm-csf receptor
RU2011127334A (ru) 2008-12-22 2013-01-27 Де Юниверсити Оф Мельбурн Лечение остеоартрита
EP3381471B1 (de) 2008-12-22 2024-03-20 The University of Melbourne Schmerzbehandlung
AU2010302961A1 (en) * 2009-10-01 2012-04-19 Csl Limited Method of treatment of philadelphia chromosome positive leukaemia
JP6426001B2 (ja) 2011-11-17 2018-11-21 グリア エスピー ゼット．オー．オー． 神経膠腫を治療するための組成物および方法
CA3108192A1 (en) 2012-12-14 2014-06-19 Biontech Rna Pharmaceuticals Gmbh Novel mhc-independent tumor-associated antigens
RU2727451C2 (ru) 2014-12-05 2020-07-21 Сити Оф Хоуп Т-клетки, модифицированные химерным рецептором антигена, нацеленным на cs1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
US5109119A (en) * 1989-06-06 1992-04-28 Schering Corporation Crystalline r-h-gm-csf and method
US5112961A (en) * 1990-07-18 1992-05-12 Schering Corporation Dna encoding subunits of a high affinity gm-csf receptor

Also Published As

Publication number Publication date
DE69031914D1 (de) 1998-02-12
CA2064814C (en) 2004-06-08
EP0486572A1 (de) 1992-05-27
AU6189690A (en) 1991-03-11
US5726036A (en) 1998-03-10
EP0486572A4 (en) 1993-05-05
CA2064814A1 (en) 1991-02-12
EP0486572B1 (de) 1998-01-07
DK0486572T3 (da) 1998-05-04
DE69031914T2 (de) 1998-07-30
US6136957A (en) 2000-10-24
JPH04507344A (ja) 1992-12-24
SG59954A1 (en) 1999-02-22
AU637133B2 (en) 1993-05-20
WO1991002063A1 (en) 1991-02-21
JP3267966B2 (ja) 2002-03-25

Similar Documents

Publication Publication Date Title
ATE161883T1 (de) Rezeptor für granulozyten-macrophagen- koloniestimulierungsfaktor und seine derivate
Li et al. Constitutive expression of growth regulated oncogene (gro) in human colon carcinoma cells with different metastatic potential and its role in regulating their metastatic phenotype
Giri et al. Identification and cloning of a novel IL‐15 binding protein that is structurally related to the alpha chain of the IL‐2 receptor.
Wolf et al. Granulocyte chemotactic protein 2 acts via both IL‐8 receptors, CXCR1 and CXCR2
Prystowsky et al. Alloreactive cloned T cell lines. VI. Multiple lymphokine activities secreted by helper and cytolytic cloned T lymphocytes.
Kelso et al. Secretion of interleukin 2, macrophage-activating factor, interferon, and colony-stimulating factor by alloreactive T lymphocyte clones.
DE60009533T2 (de) Multiple analyse von zytokinen
NO875476L (no) Elektrokjemiluminiscente analyser.
US6028176A (en) High-affinity interleukin-4 muteins
ATE273384T1 (de) Tie-2 liganden, herstellungsverfahren und verwendung
CA2177838A1 (en) A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling
CA2078118A1 (en) Cc-1065 analogs
Mergenhagen Thymocyte activating factor (s) in human gingival fluids
DE69637155D1 (de) Addressine der schleimhaut und der blutgefässe und ihre verwendung
Culouscou et al. Biochemical analysis of the epithelin receptor
King et al. Identification of unique truncated KC/GROβ chemokines with potent hematopoietic and anti-infective activities
Malone et al. Production of granulocyte-macrophage colony-stimulating factor by primary cultures of unstimulated rat microvascular endothelial cells
Yoshimura et al. Human monocyte chemoattractant protein-1 (MCP-1)
Garrison et al. Interferon-β inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines
ATE181928T1 (de) Für den rezeptor des granulozytenkolonie stimulierenden faktors kodierende dns
CA2218372C (en) Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
KR20000067914A (ko) 고친화성 인터루킨-4 뮤테인
Dore et al. IL‐6 and soluble IL‐6 receptors (sIL‐6R and sgp130) in human pleural effusions: massive IL‐6 production independently of underlying diseases
Hadden et al. Mixed interleukins and thymosin fraction V synergistically induce T lymphocyte development in hydrocortisone-treated aged mice
Olivier et al. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time